Please complete the CAPTCHA to continue
@vincerx.com
✓
4 phones found area 510, 818, and 650
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Chris Lowe is listed as CEO at Nusano at Nusano, based in West Valley City, Utah, United States. AeroLeads shows a work email signal at vincerx.com, phone signal with area code 510, 818, 650, and a matched LinkedIn profile for Chris Lowe.
Chris Lowe previously worked as Chief Executive Officer at Nusano and Board Member at Vincerx Pharma. Chris Lowe holds Bs, Finance from California Polytechnic State University-San Luis Obispo.
This section adds company-level context without repeating Chris Lowe's masked contact details.
AeroLeads found 1 current-domain work email signal for Chris Lowe. Compare company email patterns before reaching out.
I have over 15 years of senior management experience as CFO, CBO and CEO of various private and public life sciences, medical technology, and technology companies. Additionally, I have served as a member of the Board of Directors of both public and private companies, and have chaired their respective Audit Committees and Compensation Committees. My successes include assisting early stage companies with corporate and financial strategy, including seed financing, venture fundraising and IPOs, as well as Wall Street communications, licensing transactions, M&A, restructurings and coaching at every level of the C-Suite. My C-level accomplishments include:-raised over $500M in private and public financings-completed over $1.0B in M&A transactions-negotiated over $300M in debt instruments-overseen three SOX-404 implementationsContact me at clowe@flgpartners.com
Listed skills include Mergers And Acquisitions, Start Ups, Venture Capital, Ipo, and 16 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Valencia, California, US
Nusano is a privately-held medical technology company committed to bringing stability and innovation to the rapidly emerging and critically undersupplied medical radioisotopes market. Nusano’s production platform combines time-proven technology from universities and world-class research centers with the company’s patented particle acceleration technology..
Palo Alto, California, US
Vincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx’s executive team has assembled a management team of biopharmaceutical experts with extensive.
South San Francisco, California, US
Cortexyme is developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific pathogen tied to neurodegeneration. The target has been validated in a number of animal models and a Phase 1 study. Cortexyme is initiating a Phase 2 of its lead small molecule COR-388 in.
Orlando, Florida, US
Innventus Fund completed a 1st close in 2018, targeted assets under management is $150M for the fund. We partner with Fortune 100 companies to commercialize innovative technologies to transform markets.Our strategy is to partner with multinational corporations and institutional innovators, becoming their premier systematic value creation engine. Procter &.
Palo Alto, CA, US
FLG Partners is the premier solution for comprehensive board advisory and CFO consulting services for Silicon Valley companies, ranging from A-round to billion dollar public companies. While nearly all our clients have Silicon Valley roots, many of the investors in our clients invest around the world. As a result, our clients extend far beyond Silicon.
Inspyr Therapeutics, Inc. is a biotechnology company focused on the development and commercialization of promising, new therapeutics. Our work is motivated by a commitment to innovation and helping patients. We combine our powerful insights and rigorous scientific methods to create new treatment options for patients.Mipsagargin, our lead agent, is in human.
EpiBiome is a precision microbiome engineering company whose mission is to surveil bacterial populations and to develop effective and sustainable FDA-approved therapies to combat infectious diseases in humans and in agriculture without the use of shared-class antibiotics. Instead of antibiotics, the company deploys non-GMO, bacteria-specific viruses.
Mountain View, California, US
Chief Executive Officer - February 2014 - PresentChairman of Audit CommitteeChairman of Compensation Committee
Quick answers generated from the profile data available on this page.
Chris Lowe works for Nusano.
Chris Lowe is listed as CEO at Nusano at Nusano.
AeroLeads has found 1 work email signal at @vincerx.com for Chris Lowe at Nusano.
AeroLeads has found 4 phone signal(s) with area code 510, 818, 650 for Chris Lowe at Nusano.
Chris Lowe is based in West Valley City, Utah, United States while working with Nusano.
Chris Lowe has worked for Nusano, Vincerx Pharma, Cortexyme, Inc., Innventure - A Wasson Enterprise Partnership, and Flg Partners.
You can use AeroLeads to view verified contact signals for Chris Lowe at Nusano, including work email, phone, and LinkedIn data when available.
Chris Lowe holds Bs, Finance from California Polytechnic State University-San Luis Obispo.
Chris Lowe is listed with skills including Mergers And Acquisitions, Start Ups, Venture Capital, Ipo, Biotechnology, Finance, Pharmaceutical Industry, and Due Diligence.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts